A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE

Heather Payne(University College London Hospitals NHS Foundation Trust), Maria De Santis(Medical University of Vienna), Roberto Bordonaro(Ospedale Garibaldi), David Mott(Office Of Health Economics), Serena Hilman(Weston General Hospital), Angus Robinson(Royal Sussex County Hospital), M. Mira Flores(Hospital Universitari Arnau de Vilanova), Josep Gumà(Institut de Recerca Biomèdica Catalunya Sud), Bernard Rappe(Onze Lieve Vrouwziekenhuis Hospital), A. Pranzo(Astellas Pharma (United Kingdom)), A. Serikoff(Honeywell (France)), Ugo De Giorgi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Marco Pavesi(Office Of Health Economics), S. Mallick(Hôpital Saint-Michel), A Meno Duran(Astellas Pharma (United Kingdom)), Benoît Baron(Astellas Pharma (Netherlands)), Steven Joniau, Mike Herdman(Office Of Health Economics), L.M. Dourthe(Centre Hospitalier Sainte-Anne)
International Journal of Cancer
October 17, 2021
10.1002/ijc.33845
Cited by 19

Related Papers

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
|The Lancet|2015|2k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2017|1.4k
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|649